Top list · Worldwide · 2026
896 biotech startups that raised in 2026 have raised money in rounds we track in 2026. These are the 50 that raised the most, $37B between them, with the United States the most common home.
GPN Vaccines is a clinical-stage biotechnology company based in Adelaide and Canberra, Australia, founded in 2017.
Founded 2017Canberra, United States$10Blast round Nov 2026Isomorphic Labs is a London-based artificial intelligence company focused on transforming the drug discovery process.
Founded 2021London, United Kingdom$2.1Blast round May 2026Revolution Medicines is an innovative and dynamic organization of expert biologists, chemists, pharmacologists, clinical scientists.
Founded 2015Redwood City, United States$1.5Blast round Apr 2026Neko Health is a health-tech company based in Stockholm, Sweden, founded in 2018 by Daniel Ek and Hjalmar Nilsonne.
Founded 2018Stockholm, Sweden$1.4Blast round Sept 2026Mirendil is an AI research lab that creates self-accelerating systems that convert computing power into scientific advancements.
Founded -San Francisco, United States$1.4Blast round Nov 2026Apogee Therapeutics is a biotechnology company that offers therapies for immunological and inflammatory disorders.
Founded 2022San Francisco, United States$1.3Blast round May 2026BridgeBio focuses on the development and commercialization of precision medicines for various genetic diseases and cancers.
Founded 2015Palo Alto, United States$1.0Blast round Jul 2026Definium Therapeutics provides psychedelic-inspired medicines and therapies for substance abuse disorders and other mental illnesses.
Founded -New York, United States$805Mlast round Jun 2026Oruka Therapeutics is advancing innovative biologics to redefine patient care standards in chronic skin diseases.
Founded -Waltham, United States$700Mlast round Apr 2026Erasca is a developer of oncology drugs intended to provide precision oncology options.
Founded 2018San Diego, United States$633Mlast round Jul 2026Telix Pharmaceuticalsis a clinical-stage biotechnology company focused on the development of diagnostic and therapeutic products.
Founded -Melbourne, Australia$600Mlast round Apr 2026Tango Therapeutics is a biotechnology company that is developing next generation cancer therapies.
Founded 2017Cambridge, United States$600Mlast round Jun 2026Mirum Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of therapies.
Founded 2018Foster City, United States$600Mlast round May 2026WHOOP is a performance optimization system that tracks athlete recovery, training, and sleeping hours to help boost performance.
Founded 2012Boston, United States$575Mlast round Mar 2026CRISPR Therapeutics is focused on the development of transformative medicines using its proprietary CRISPR/Cas9 gene-editing platform.
Founded 2014United States$550Mlast round Mar 2026Candid Therapeutics was a clinical-stage biotechnology company based in San Diego, California, founded in 2024.
Founded 2024San Diego, United States$505Mlast round Mar 2026Celcuity is a biotechnology company translating discoveries of new cancer sub-types into expanded therapeutic options for cancer patients.
Founded 2011Hamel, United States$500Mlast round Jun 2026Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.
Founded 2019Boulder, United States$460Mlast round Jun 2026NewLimit is a biotechnology company based in South San Francisco, California, focused on extending human healthspan through innovative medicines that restore yo
Founded 2022South San Francisco, United States$435Mlast round Jun 2026Avalo Therapeutics is a clinical-stage biopharmaceutical company.
Founded 2011Rockville, United States$431Mlast round May 2026Spyre Therapeutics is a biotechnology business that is developing a strong pipeline of antibody therapies.
Founded -Sunrise, United States$403Mlast round Apr 2026CMR Surgical is a British medical device company based in Cambridge, UK, focused on developing and manufacturing robot-assisted surgery systems.
Founded 2014Milton, United Kingdom$400Mlast round Oct 2026Tyra Biosciences is a biotechnology company targeting new pathways of acquired resistance in oncology with purpose-built drugs.
Founded 2018Carlsbad, United States$400Mlast round Sept 2026Chai Discovery is an artificial intelligence biotechnology company based in San Francisco, California, founded in March 2024.
Founded -San Francisco, United States$400Mlast round Jul 2026Intellia Therapeutics is a genome editing company that develops curative gene-editing treatments.
Founded 2014Cambridge, United States$400Mlast round Sept 2026Immunic is a biopharmaceutical company that develops a pipeline of selective oral immunology therapies.
Founded 2016New York, United States$400Mlast round Feb 2026Dyne Therapeutics is a developer of targeted therapies intended for serious muscle diseases.
Founded 2018Waltham, United States$375Mlast round Jul 2026OMass Therapeutics is a biotechnology company located in Oxford, UK, focused on discovering and developing novel small molecule medicines for rare diseases and
Founded 2016Oxford, United Kingdom$363Mlast round Oct 2026Dren Bio focuses on protein engineering technologies for depletion of cells, protein aggregates, and other disease-causing agents.
Founded 2019Foster City, United States$350Mlast round Oct 2026Doctolib is an online and mobile booking platform that helps users find doctors and make appointments.
Founded 2013Levallois-Perret, France$346Mlast round Apr 2026Alumis is a precision medicine company focused on the discovery, development and treatment of autoimmune disorders.
Founded 2021San Francisco, United States$345Mlast round Jan 2026IDEAYA Biosciences is an oncology-focused biotechnology company that develops therapeutics for patients with genetically-defined cancers.
Founded 2015South San Francisco, United States$345Mlast round Jun 2026AdvanCell is radiopharmaceutical firm that has developed the Targeted Alpha Therapy platform technology, a cutting-edge cancer treatment.
Founded 2019Sydney, Australia$315Mlast round Jul 2026The purpose of Idorsia is to discover, develop and commercialize innovative medicines to help more patients.
Founded 2017Allschwil, Switzerland$314Mlast round Jun 2026Learn how Verily's AI-native data platform unifies complex health data with robust governance, accelerating research and care to deliver real-world impact for p
Founded -South San Francisco, United States$300Mlast round Mar 2026Artiva Biotherapeutics is a biotech company focused on developing and commercializing allogeneic natural killer (NK) cell therapies.
Founded 2019San Diego, United States$300Mlast round May 2026Monte Rosa Therapeutics is a biotechnology company that develops cancer therapeutics that modulate protein degradation pathways.
Founded 2018Basel, Switzerland$300Mlast round Jan 2026Beeline Medicines is a clinical-stage biotechnology company based in Boston, Massachusetts, focused on developing precision therapies for autoimmune and inflamm
Founded 2025Stamford, United States$300Mlast round Apr 2026CORXEL Pharmaceuticals is a clinical-stage biopharmaceutical company founded in 2019, previously known as JiXing Pharmaceuticals.
Founded 2019Berkeley Heights, United States$287Mlast round Jan 2026Brain Co.
Founded -San Francisco, United States$286Mlast round Jan 2026CellCentric is a clinical-stage biopharmaceutical company based in Cambridge, UK.
Founded 2004Saffron Walden, United Kingdom$285Mlast round May 2026Relay therapeutics is a developer of an allosteric drug-discovery platform intended to apply computational techniques to protein motion.
Founded 2016Cambridge, United States$275Mlast round May 2026Encoded Therapeutics is a Harnessing the regulatory genome to create next-generation molecular therapies.
Founded 2014South San Francisco, United States$275Mlast round Sept 2026Galecto is a clinical stage biotechnology company focused on the development of novel treatments for fibrosis and cancer.
Founded 2011Copenhagen, Denmark$275Mlast round Feb 2026Cellares is a biotechnology company based in South San Francisco, California, and is recognized as the world’s first Integrated Development and Manufacturing Or
Founded 2019South San Francisco, United States$257Mlast round Jan 2026Merge Labs provides a single API to connect software applications with multiple third-party platforms.
Founded 2016San Francisco, United States$252Mlast round Jan 2026Companies with a round in 2026 that we track, ranked by what they raised this year. Nobody pays to be on a list.
Open any company for its rounds and investors, or search the investors who back biotech startups that raised in 2026 in the app, with filters, lists and exports.
IL
NH
CSBiotech startups in Europe1,665 companies · $22B
IL
CS
ONBiotech startups in the United Kingdom588 companies · $15B
GV
RM
MBiotech startups in the United States that raised in 2026498 companies · $32B in 2026
NH
DT
EBiotech startups founded in 2018368 companies · $14BNR
LL
STBiotech startups founded in 2020337 companies · $7.0B
E
NABiotech startups founded in 2019336 companies · $11B
IL
RB
VSBiotech startups founded in 2021275 companies · $12B
WC
GV
V
RPHealth startups worldwide12,811 companies · $81B
O
A
XAI startups worldwide10,238 companies · $830B
GV
V
RPBiotech startups worldwide7,127 companies · $70B
D
B
FTBig data startups worldwide3,812 companies · $220BAF
R
SFintech startups worldwide3,200 companies · $94B
O
A
BAI startups that raised in 20262,922 companies · $540B in 2026
FT
CE
PEnergy providers startups worldwide2,808 companies · $152B
P
OMarketing tech startups worldwide2,728 companies · $28B